PBLA logo

Panbela Therapeutics (PBLA)

Profile

Full Name

Panbela Therapeutics, Inc.

Ticker Symbol

PBLA

Exchange

NASDAQ

Country

United States

IPO

January 3, 2017

Indexes

Not included

Employees

7

Key Details

Price

$0.27(-15.34%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$316.52(+98.42% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Aug 15, 24 HC Wainwright & Co.
Neutral
Jun 24, 24 HC Wainwright & Co.
Neutral
May 16, 24 HC Wainwright & Co.
Neutral
Apr 2, 24 HC Wainwright & Co.
Buy
Mar 27, 24 Roth MKM
Buy
Feb 5, 24 Roth MKM
Buy
Dec 18, 23 Roth MKM
Buy
Aug 11, 23 HC Wainwright & Co.
Buy
Jul 24, 23 HC Wainwright & Co.
Buy
Jul 10, 23 HC Wainwright & Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Panbela Therapeutics?
  • Does Panbela Therapeutics pay dividends?
  • What sector is Panbela Therapeutics in?
  • What industry is Panbela Therapeutics in?
  • What country is Panbela Therapeutics based in?
  • When did Panbela Therapeutics go public?
  • Is Panbela Therapeutics in the S&P 500?
  • Is Panbela Therapeutics in the NASDAQ 100?
  • Is Panbela Therapeutics in the Dow Jones?
  • When was Panbela Therapeutics's last earnings report?
  • When does Panbela Therapeutics report earnings?
  • Should I buy Panbela Therapeutics stock now?

What is the ticker symbol for Panbela Therapeutics?

The ticker symbol for Panbela Therapeutics is NASDAQ:PBLA

Does Panbela Therapeutics pay dividends?

No, Panbela Therapeutics does not pay dividends

What sector is Panbela Therapeutics in?

Panbela Therapeutics is in the Healthcare sector

What industry is Panbela Therapeutics in?

Panbela Therapeutics is in the Biotechnology industry

What country is Panbela Therapeutics based in?

Panbela Therapeutics is headquartered in United States

When did Panbela Therapeutics go public?

Panbela Therapeutics's initial public offering (IPO) was on January 3, 2017

Is Panbela Therapeutics in the S&P 500?

No, Panbela Therapeutics is not included in the S&P 500 index

Is Panbela Therapeutics in the NASDAQ 100?

No, Panbela Therapeutics is not included in the NASDAQ 100 index

Is Panbela Therapeutics in the Dow Jones?

No, Panbela Therapeutics is not included in the Dow Jones index

When was Panbela Therapeutics's last earnings report?

Panbela Therapeutics's most recent earnings report was on Nov 14, 2024

When does Panbela Therapeutics report earnings?

The next expected earnings date for Panbela Therapeutics is May 15, 2025

Should I buy Panbela Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page